PTO Hunts Southeast Spots for Inventor Outreach Offices
Published Date: 2/26/2026
Notice
Summary
The Patent and Trademark Office wants your ideas on where to open new community outreach offices in the Southeast, covering 10 states like Florida and Georgia. These offices will help inventors and businesses connect better with the government. If you want to share your thoughts, send them by March 30, 2026—no public meetings, just your written comments!
Analyzed Economic Effects
4 provisions identified: 4 benefits, 0 costs, 0 mixed.
COOs Required in Southeast States
If you are in Virginia, North Carolina, South Carolina, Georgia, Florida, Tennessee, Alabama, Mississippi, Louisiana, or Arkansas, the USPTO is seeking locations for one or more Community Outreach Offices (COOs) to serve those states. The Unleashing American Innovators Act requires the USPTO to establish at least four COOs no later than December 29, 2027.
COOs Will Provide Pro Bono Outreach
The USPTO says COOs will educate prospective innovators—including individual inventors, small businesses, veterans, low-income populations, and students—about public and private resources available to applicants, including pro bono programs. That means people in the listed Southeast states could get local help and referrals for patent-related resources and pro bono assistance.
COOs Aim to Speed Patent Processing
The USPTO notes that regional offices and COOs aim to improve examiner recruitment and retention, decrease the number of patent applications waiting for examination, and improve examination quality. That could lead to faster or higher-quality patent examination for applicants in the states served by new COOs.
Focus on Emerging Tech Outreach
The USPTO states COOs will incentivize regional innovation and entrepreneurship, especially in emerging areas such as artificial intelligence (AI), quantum, and distributed ledger technologies. Innovators and students in those fields in the listed Southeast states may see targeted outreach, education, or partnership programs.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16744, Request for Comments on Community Outreach Office Locations in the Southwest States
The USPTO wants your ideas on where to open new community outreach offices in the Southwest states like Arizona and Texas. These offices will help inventors, small businesses, and students get better support with patents. Share your thoughts by September 16, 2026, so the USPTO can pick the best spots and keep innovation booming without extra costs to you!
2026-16315, Administrative Updates to the General Requirements Bulletin for Admission to the Examination for Registration To Practice in Patent Cases Before the United States Patent and Trademark Office
Starting August 11, 2026, the USPTO is upgrading Biomedical Science degrees from Category B to Category A for patent bar eligibility. This means more people with this degree can now take the patent exam and become patent practitioners. No extra fees or delays—just a smoother path for those with the right science background to join the patent world!
2026-14939, Grant of Interim Extension of the Term of U.S. Patent No. 8,877,798; Centanafadine Hydrochloride
Otsuka America Pharmaceutical got a one-year extra patent life for their drug centanafadine hydrochloride because the FDA review is still going on. This means their patent, which was set to expire on July 25, 2026, now lasts until July 25, 2027. This extension helps Otsuka keep exclusive rights to their drug a bit longer while waiting for final FDA approval.
2026-14941, Grant of Interim Extension of the Term of U.S. Patent No. 8,461,196; Centanafadine Hydrochloride
Otsuka America Pharmaceutical got a one-year extra patent life for their drug centanafadine hydrochloride because the FDA review is still going on. This means they keep exclusive rights to the drug until July 25, 2027, giving them more time to sell it without competition. This extension helps the company protect their investment while the drug gets final approval.
2026-14793, Requirement To Identify All Real Parties in Interest to a Third Party Request for an Ex Parte Reexamination
The USPTO wants anyone asking for a third-party ex parte reexamination to clearly say who’s really behind the request. This helps stop sneaky tricks and keeps the process honest. If you’re involved, get ready to share this info confidentially by August 21, 2026, or risk delays or issues.
2026-14389, Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Response to Office Action and Voluntary Amendment Forms
The USPTO is asking for public feedback on updating forms used to respond to trademark office actions and make voluntary changes. This affects anyone applying for or managing trademarks and could streamline the process without extra costs. Comments are open until September 15, 2026, so don’t miss your chance to weigh in!
Previous / Next Documents
Previous: 2026-03859, Revision to and Extension of Approval of an Information Collection; 7 CFR Part 340; Introduction of Organisms and Products Altered or Produced Through Genetic Engineering
The USDA’s Animal and Plant Health Inspection Service is updating and extending the paperwork rules for bringing genetically engineered plants and organisms into the country. This affects scientists, companies, and farmers who work with these modified products. You’ve got until April 27, 2026, to share your thoughts, and these changes help keep the process smooth without adding extra costs.
Next: 2026-03861, Takes of Marine Mammals Incidental to Specified Activities; Taking Marine Mammals Incidental to the Demolition of Pier 10 and Construction of a Crane Weight Test Area Project at U.S. Naval Submarine Base New London
The U.S. Navy plans to tear down Pier 10 and build a Crane Weight Test Area at the Naval Submarine Base in New London, Connecticut. This work might disturb local marine mammals, so NOAA is asking for public comments before deciding on a special permit that lets the Navy do this with some limits. Comments are open until March 30, 2026, and there’s a chance for a one-year permit renewal if needed.